Highlight
Summary
About the Role
About You
- Bachelor’s degree in Life Sciences, Biotechnology, Bioengineering, or a related field.
- 3+ years of experience in product management, marketing, or technical role in life sciences, biotech, or CGT-related fields.
- Understanding of cell and gene therapy processes or adjacent bioprocessing workflows.
- Proficient presentation skills to convey technical information to large groups.
- Ability to travel domestically and internationally (up to 30%).
- Advanced degree (MS, MBA, or PhD) is a plus.
Benefits
- Base salary range: $112k–$120k.
- Eligible for an annual bonus plan with a target of 10% of the base salary.
- 401(k) plan with company contributions.
- Paid vacation, holiday and personal days.
- Employee assistance program.
- Health benefits including medical, prescription drug, dental and vision coverage.
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With more than 43,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of almost 450 million patients annually. With Vision 2026, as part of the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. For more information, please visit www.fresenius-kabi.com/us.